课题基金 / 基金详情

Net Clinical Benefit and Cost-Effectiveness of Indefinite Anticoagulation Among Clinically Relevant Subgroups of Patients with First Unprovoked Venous Thromboembolism

Net Clinical Benefit and Cost-Effectiveness of Indefinite Anticoagulation Among Clinically Relevant Subgroups of Patients with First Unprovoked Venous Thromboembolism
首次无端静脉血栓栓塞临床相关亚组患者无限期抗凝的净临床效益和成本效益
批准号：
493128
负责人：
Khan Faizan
金额：
$0.11万
依托单位：
University of Calgary
依托单位国家：
加拿大
项目类别：
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=493128&lang=en
关键词：
Venous Thromboembolism (Vte)

项目摘要

项目成果

Khan Faizan的其他基金

相关文献

中文摘要
翻译
对于腿部静脉或肺部动脉中不明原因的血栓（统称为静脉血栓栓塞），在完成3至6个月的初始治疗后，临床实践指南建议继续使用血液稀释剂治疗
英文摘要
After completing 3 to 6 months of initial treatment for unexplained blood clots either in the leg veins or the lung arteries, collectively knows as venous thromboembolism (VTE), clinical practice guidelines suggest continuing treatment with blood thinners
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-Developing a Transitions in Care Bundle for Critically Ill Patients and Their Family Caregivers
  • 批准号：
    471248
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $10.2万
  • 财政年份：
    2022
  • 负责人：
    Khan Faizan
  • 依托单位：
    University of Calgary
Co-Developing a Transitions in Care Bundle for Critically Ill Patients and Their Family Caregivers
What is the optimal duration of anticoagulant therapy for patients with a first episode of unprovoked venous thromboembolism?
  • 批准号：
    387252
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2017
  • 负责人：
    Khan Faizan
  • 依托单位：
    Ottawa Hospital Research Institute
Cost-Effectiveness of Indefinite Versus Short-Term Anticoagulation for the Prevention of Recurrent Venous Thromboembolism in Unprovoked Venous Thromboembolism Patients
  • 批准号：
    350194
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2015
  • 负责人：
    Khan Faizan
  • 依托单位：
    University of Ottawa